-
1
-
-
0034989269
-
Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock
-
10.1016/S0896-6273(01)00302-6 11395012
-
Bae K. Jin X. Maywood E.S. Hastings M.H. Reppert S.M. Weaver D.R. 2001. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron, 30 (2): 525-536. 10.1016/S0896-6273(01)00302-6 11395012
-
(2001)
Neuron
, vol.30
, Issue.2
, pp. 525-536
-
-
Bae, K.1
Jin, X.2
Maywood, E.S.3
Hastings, M.H.4
Reppert, S.M.5
Weaver, D.R.6
-
2
-
-
42949165854
-
PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival
-
10.1016/j.molcel.2008.02.024 18439899
-
Bozulic L. Surucu B. Hynx D. Hemmings B.A. 2008. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell, 30 (2): 203-213. 10.1016/j.molcel.2008.02.024 18439899
-
(2008)
Mol. Cell
, vol.30
, Issue.2
, pp. 203-213
-
-
Bozulic, L.1
Surucu, B.2
Hynx, D.3
Hemmings, B.A.4
-
3
-
-
45749098900
-
AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition
-
10.1124/mol.107.044743 18413665
-
Caporali S. Levati L. Starace G. Ragone G. Bonmassar E. Alvino E. D'Atri S. 2008. AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. Mol. Pharmacol. 74 (1): 173-183. 10.1124/mol.107.044743 18413665
-
(2008)
Mol. Pharmacol.
, vol.74
, Issue.1
, pp. 173-183
-
-
Caporali, S.1
Levati, L.2
Starace, G.3
Ragone, G.4
Bonmassar, E.5
Alvino, E.6
D'Atri, S.7
-
4
-
-
22844451414
-
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers
-
10.1093/carcin/bgi075 15790588
-
Chen S.T. Choo K.B. Hou M.F. Yeh K.T. Kuo S.J. Chang J.G. 2005. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis, 26 (7): 1241-1246. 10.1093/carcin/bgi075 15790588
-
(2005)
Carcinogenesis
, vol.26
, Issue.7
, pp. 1241-1246
-
-
Chen, S.T.1
Choo, K.B.2
Hou, M.F.3
Yeh, K.T.4
Kuo, S.J.5
Chang, J.G.6
-
5
-
-
44149115749
-
The potential role of Akt phosphorylation in human cancers
-
18409144
-
Cicenas J. 2008. The potential role of Akt phosphorylation in human cancers. Int. J. Biol. Markers, 23 (1): 1-9. 18409144
-
(2008)
Int. J. Biol. Markers
, vol.23
, Issue.1
, pp. 1-9
-
-
Cicenas, J.1
-
6
-
-
0037020198
-
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
-
10.1016/S0092-8674(02)00961-3 12372299
-
Fu L. Pelicano H. Liu J. Huang P. Lee C. 2002. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell, 111 (1): 41-50. 10.1016/S0092-8674(02)00961-3 12372299
-
(2002)
Cell
, vol.111
, Issue.1
, pp. 41-50
-
-
Fu, L.1
Pelicano, H.2
Liu, J.3
Huang, P.4
Lee, C.5
-
7
-
-
23044446771
-
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints and Cancer
-
10.1158/0008-5472.CAN-05-1119 16061665
-
Gauger M.A. Sancar A. 2005. Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints and Cancer. Cancer Res. 65 (15): 6828-6834. 10.1158/0008-5472.CAN- 05-1119 16061665
-
(2005)
Cancer Res.
, vol.65
, Issue.15
, pp. 6828-6834
-
-
Gauger, M.A.1
Sancar, A.2
-
8
-
-
77949404318
-
Per2 is a C/EBP target gene implicated in myeloid leukemia
-
10.1177/1534735409352084 19926610
-
Gery S. Koeffler H.P. 2009. Per2 is a C/EBP target gene implicated in myeloid leukemia. Integr. Cancer Ther. 8 (4): 317-320. 10.1177/1534735409352084 19926610
-
(2009)
Integr. Cancer Ther.
, vol.8
, Issue.4
, pp. 317-320
-
-
Gery, S.1
Koeffler, H.P.2
-
9
-
-
27144442071
-
Transcriptional profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemias
-
10.1182/blood-2005-01-0358 15985538
-
Gery S. Gombart A.F. Yi W.S. Koeffler C. Hofmann W.K. Koeffler H.P. 2005. Transcriptional profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemias. Blood, 106 (8): 2827-2836. 10.1182/blood-2005-01-0358 15985538
-
(2005)
Blood
, vol.106
, Issue.8
, pp. 2827-2836
-
-
Gery, S.1
Gombart, A.F.2
Yi, W.S.3
Koeffler, C.4
Hofmann, W.K.5
Koeffler, H.P.6
-
10
-
-
33646084831
-
The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells
-
10.1016/j.molcel.2006.03.038 16678109
-
Gery S. Komatsu N. Baldjyan L. Yu A. Koo D. Koeffler H.P. 2006. The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell, 22 (3): 375-382. 10.1016/j.molcel. 2006.03.038 16678109
-
(2006)
Mol. Cell
, vol.22
, Issue.3
, pp. 375-382
-
-
Gery, S.1
Komatsu, N.2
Baldjyan, L.3
Yu, A.4
Koo, D.5
Koeffler, H.P.6
-
11
-
-
0035437146
-
DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway
-
10.1182/blood.V98.3.834 11468186
-
Henry M.K. Lynch J.T. Eapen A.K. Quelle F.W. 2001. DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood, 98 (3): 834-841. 10.1182/blood.V98.3.834 11468186
-
(2001)
Blood
, vol.98
, Issue.3
, pp. 834-841
-
-
Henry, M.K.1
Lynch, J.T.2
Eapen, A.K.3
Quelle, F.W.4
-
12
-
-
19644373959
-
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence
-
10.1158/0008-5472.CAN-04-2633 15930307
-
Hirose Y. Katayama M. Mirzoeva O.K. Berger M.S. Pieper R.O. 2005. Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res. 65 (11): 4861-4869. 10.1158/0008-5472.CAN-04-2633 15930307
-
(2005)
Cancer Res.
, vol.65
, Issue.11
, pp. 4861-4869
-
-
Hirose, Y.1
Katayama, M.2
Mirzoeva, O.K.3
Berger, M.S.4
Pieper, R.O.5
-
13
-
-
33745941964
-
Circadian gene mPer2 overexpression induces cancer cell apoptosis
-
10.1111/j.1349-7006.2006.00225.x 16827798
-
Hua H. Wang Y. Wan C. Liu Y. Zhu B. Yang C. et al. 2006. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97 (7): 589-596. 10.1111/j.1349-7006.2006.00225.x 16827798
-
(2006)
Cancer Sci.
, vol.97
, Issue.7
, pp. 589-596
-
-
Hua, H.1
Wang, Y.2
Wan, C.3
Liu, Y.4
Zhu, B.5
Yang, C.6
-
14
-
-
34547862425
-
Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice
-
10.1038/sj.cgt.7701061 17589433
-
Hua H. Wang Y. Wan C. Liu Y. Zhu B. Wang X. et al. 2007. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther. 14 (9): 815-818. 10.1038/sj.cgt.7701061 17589433
-
(2007)
Cancer Gene Ther.
, vol.14
, Issue.9
, pp. 815-818
-
-
Hua, H.1
Wang, Y.2
Wan, C.3
Liu, Y.4
Zhu, B.5
Wang, X.6
-
15
-
-
79952703587
-
Tumor clock protein PER2 as a determinant of survival in patients receiving oxaliplatin-5-FU-leucovorin as first-line chemotherapy for metastatic colorectal cancer
-
Abstract No. 11032
-
Iacobelli S. Innominato P.F. Piantelli M. Bjarnason G. Coudert B. Focan C. et al. 2008. Tumor clock protein PER2 as a determinant of survival in patients receiving oxaliplatin-5-FU-leucovorin as first-line chemotherapy for metastatic colorectal cancer. J. Clin. Oncol. 26 May Suppl.,. Abstract No. 11032.
-
(2008)
J. Clin. Oncol.
, vol.26
, Issue.MAY AND SUPPL.
-
-
Iacobelli, S.1
Innominato, P.F.2
Piantelli, M.3
Bjarnason, G.4
Coudert, B.5
Focan, C.6
-
16
-
-
78649668031
-
Per3, a circadian gene, is required for chk2 activation in human cells
-
10.1016/j.febslet.2010.11.003 21070773
-
Im J.-S. Jung B.-H. Kim S.-E. Lee K.-H. Lee J.-K. 2010. Per3, a circadian gene, is required for chk2 activation in human cells. FEBS Lett. 584 (23): 4731-4734. 10.1016/j.febslet.2010.11.003 21070773
-
(2010)
FEBS Lett.
, vol.584
, Issue.23
, pp. 4731-4734
-
-
Im, J.-S.1
Jung, B.-H.2
Kim, S.-E.3
Lee, K.-H.4
Lee, J.-K.5
-
17
-
-
0036841293
-
Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage
-
10.1128/MCB.22.22.7831-7841.2002 12391152
-
Kandel E.S. Skeen J. Majewski N. Di Cristofano A. Pandolfi P.P. Feliciano C.S. et al. 2002. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol. Cell. Biol. 22 (22): 7831-7841. 10.1128/MCB.22.22.7831-7841.2002 12391152
-
(2002)
Mol. Cell. Biol.
, vol.22
, Issue.22
, pp. 7831-7841
-
-
Kandel, E.S.1
Skeen, J.2
Majewski, N.3
Di Cristofano, A.4
Pandolfi, P.P.5
Feliciano, C.S.6
-
18
-
-
66849113849
-
AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells
-
10.4161/cc.8.10.8547 19377290
-
Lal M.A. Bae D. Camilli T.C. Patierno S.R. Ceryak S. 2009. AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells. Cell Cycle, 8 (10): 1589-1602. 10.4161/cc.8.10.8547 19377290
-
(2009)
Cell Cycle
, vol.8
, Issue.10
, pp. 1589-1602
-
-
Lal, M.A.1
Bae, D.2
Camilli, T.C.3
Patierno, S.R.4
Ceryak, S.5
-
19
-
-
2342618936
-
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression
-
10.4161/cc.2.4.433 12851486
-
Liang J. Slingerland J.M. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle, 2 (4): 336-342. 10.4161/cc.2.4.433 12851486
-
(2003)
Cell Cycle
, vol.2
, Issue.4
, pp. 336-342
-
-
Liang, J.1
Slingerland, J.M.2
-
20
-
-
77953408308
-
Physiological regulation of Akt activity and stability
-
20182580
-
Liao Y. Hung M.C. 2010. Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2 (1): 19-42. 20182580
-
(2010)
Am. J. Transl. Res.
, vol.2
, Issue.1
, pp. 19-42
-
-
Liao, Y.1
Hung, M.C.2
-
21
-
-
67650230896
-
Wnt/beta-catenin signaling: Components, mechanisms, and diseases
-
10.1016/j.devcel.2009.06.016 19619488
-
MacDonald B.T. Tamai K. He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17 (1): 9-26. 10.1016/j.devcel.2009.06.016 19619488
-
(2009)
Dev. Cell
, vol.17
, Issue.1
, pp. 9-26
-
-
MacDonald, B.T.1
Tamai, K.2
He, X.3
-
22
-
-
0141889955
-
Control mechanism of the circadian clock for timing of cell division in vivo
-
10.1126/science.1086271 12934012
-
Matsuo T. Yamaguchi S. Mitsui S. Emi A. Shimoda F. Okamura H. 2003. Control mechanism of the circadian clock for timing of cell division in vivo. Science, 302 (5643): 255-259. 10.1126/science.1086271 12934012
-
(2003)
Science
, vol.302
, Issue.5643
, pp. 255-259
-
-
Matsuo, T.1
Yamaguchi, S.2
Mitsui, S.3
Emi, A.4
Shimoda, F.5
Okamura, H.6
-
23
-
-
64949157835
-
Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin
-
19414365
-
Oda A. Katayose Y. Yabuuchi S. Yamamoto K. Mizuma M. Shirasou S. et al. 2009. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res. 29 (4): 1201-1209. 19414365
-
(2009)
Anticancer Res.
, vol.29
, Issue.4
, pp. 1201-1209
-
-
Oda, A.1
Katayose, Y.2
Yabuuchi, S.3
Yamamoto, K.4
Mizuma, M.5
Shirasou, S.6
-
24
-
-
79953050613
-
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer
-
10.3892/or.2011.1207 21380491
-
Oshima T. Takenoshita S. Akaike M. Kunisaki C. Fujii S. Nozaki A. et al. 2011. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol. Rep. 25 (5): 1439-1446. 10.3892/or.2011.1207 21380491
-
(2011)
Oncol. Rep.
, vol.25
, Issue.5
, pp. 1439-1446
-
-
Oshima, T.1
Takenoshita, S.2
Akaike, M.3
Kunisaki, C.4
Fujii, S.5
Nozaki, A.6
-
25
-
-
56449128931
-
AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51
-
10.1158/0008-5472.CAN-08-0861 19010915
-
Plo I. Laulier C. Gauthier L. Lebrun F. Calvo F. Lopez B.S. 2008. AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51. Cancer Res. 68 (22): 9404-9412. 10.1158/0008-5472.CAN-08-0861 19010915
-
(2008)
Cancer Res.
, vol.68
, Issue.22
, pp. 9404-9412
-
-
Plo, I.1
Laulier, C.2
Gauthier, L.3
Lebrun, F.4
Calvo, F.5
Lopez, B.S.6
-
26
-
-
0037194790
-
Coordination of circadian timing in mammals
-
10.1038/nature00965 12198538
-
Reppert S.M. Weaver D.R. 2002. Coordination of circadian timing in mammals. Nature, 418 (6901): 935-941. 10.1038/nature00965 12198538
-
(2002)
Nature
, vol.418
, Issue.6901
, pp. 935-941
-
-
Reppert, S.M.1
Weaver, D.R.2
-
27
-
-
57449084346
-
Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2
-
10.1161/CIRCULATIONAHA.108.790469 18981300
-
Wang C.-Y. Wen M.-S. Wang H.-W. Hsieh I.-C. Li Y. Liu P.-Y. et al. 2008. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation, 118 (21): 2166-2173. 10.1161/CIRCULATIONAHA.108.790469 18981300
-
(2008)
Circulation
, vol.118
, Issue.21
, pp. 2166-2173
-
-
Wang, C.-Y.1
Wen, M.-S.2
Wang, H.-W.3
Hsieh, I.-C.4
Li, Y.5
Liu, P.-Y.6
-
28
-
-
35448985252
-
Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors
-
10.1593/neo.07595 17971899
-
Winter S.L. Bosnoyan-Collins L. Pinnaduwage D. Andrulis I.L. 2007. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia, 9 (10): 797-800. 10.1593/neo.07595 17971899
-
(2007)
Neoplasia
, vol.9
, Issue.10
, pp. 797-800
-
-
Winter, S.L.1
Bosnoyan-Collins, L.2
Pinnaduwage, D.3
Andrulis, I.L.4
-
29
-
-
56449122777
-
Period 2 mutation accelerates ApcMin/+ tumorigenesis
-
10.1158/1541-7786.MCR-08-0196 19010825
-
Wood P.A. Yang X. Taber A. Oh E.Y. Ansell C. Ayers S.E. et al. 2008. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol. Cancer Res. 6 (11): 1786-1793. 10.1158/1541-7786.MCR-08-0196 19010825
-
(2008)
Mol. Cancer Res.
, vol.6
, Issue.11
, pp. 1786-1793
-
-
Wood, P.A.1
Yang, X.2
Taber, A.3
Oh, E.Y.4
Ansell, C.5
Ayers, S.E.6
-
30
-
-
77955464721
-
Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2
-
10.1083/jcb.201003004 20679434
-
Xu N. Hegarat N. Black E.J. Scott M.T. Hochegger H. Gillespie D.A. 2010. Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2. J. Cell Biol. 190 (3): 297-305. 10.1083/jcb.201003004 20679434
-
(2010)
J. Cell Biol.
, vol.190
, Issue.3
, pp. 297-305
-
-
Xu, N.1
Hegarat, N.2
Black, E.J.3
Scott, M.T.4
Hochegger, H.5
Gillespie, D.A.6
-
31
-
-
68949135495
-
Down-regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm
-
10.1007/s10549-008-0133-z 18651214
-
Yang X. Wood P.A. Oh E.Y. Du-Quiton J. Ansell C.M. Hrushesky W.J. 2009. Down-regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res. Treat. 117 (2): 423-431. 10.1007/s10549-008-0133-z 18651214
-
(2009)
Breast Cancer Res. Treat.
, vol.117
, Issue.2
, pp. 423-431
-
-
Yang, X.1
Wood, P.A.2
Oh, E.Y.3
Du-Quiton, J.4
Ansell, C.M.5
Hrushesky, W.J.6
-
33
-
-
0035368681
-
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock
-
10.1016/S0092-8674(01)00380-4 11389837
-
Zheng B. Albrecht U. Kaasik K. Sage M. Lu W. Vaishnav S. et al. 2001. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell, 105 (5): 683-694. 10.1016/S0092-8674(01)00380-4 11389837
-
(2001)
Cell
, vol.105
, Issue.5
, pp. 683-694
-
-
Zheng, B.1
Albrecht, U.2
Kaasik, K.3
Sage, M.4
Lu, W.5
Vaishnav, S.6
|